Proceedings of the 2nd Global Health and Innovation in conjunction with 6th ORL Head and Neck Oncology Conference (ORLHN 2021)

<Previous Article In Volume
Next Article In Volume>

Management of Stage II Sinonasal Carcinoma (T2N0M0) with Transnasal Endoscopic Resection and Radiotherapy

Authors
Riska Handriani1, 2, *, Fadhlia Fadhlia1, 2, Benny Kurnia1, 2
1Otorhinolaryngology Head and Neck Surgery Department, Faculty of Medicine, University of Syiah Kuala
2dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia
*Corresponding author. Email: riskaa_im@yahoo.com
Corresponding Author
Riska Handriani
Available Online 21 February 2022.
DOI
10.2991/ahsr.k.220206.038How to use a DOI?
Keywords
Sinonasal carcinoma; transnasal endoscopic resection; squamous cell carcinoma
Abstract

Nasoethmoidal carcinoma is a malignant tumor found in the nasal cavity and ethmoidal sinuses. The early stage is rarely found due to the similarity of symptoms inflammatory process in sinonasal. The main modality for sinonasal cancer is surgery followed by radiation as adjuvant treatment. The prognosis for early-stage sinonasal malignancy is generally good, which found a low recurrence rate. This study aims to report the management of early-stage sinonasal carcinoma. A 44-years-old male with the main symptom of left nasal blockage and bleeding since 6 months ago, physical examination showed a solitary mass at the posterior nasal septum. Histopathology result was well-differentiated squamous cell carcinoma and Paranasal sinuses CT-Scan showed a solid mass in left posterior nasal cavity extended to ethmoidal sinuses. He underwent transnasal endoscopic resection, and we suggested continuing with radiotherapy at central java. Follow-up 2 months after radiotherapy, we performed a biopsy, and histopathology revealed a chronic inflammatory process without malignancy, paranasal sinuses CT Scan n physical examination within normal limits. Transnasal endoscopic resection followed by radiotherapy is an appropriate and effective treatment for sinonasal carcinoma in the early stage. A case of limited-stage II sinonasal carcinoma with transnasal endoscopic resection surgery followed by radiotherapy has been reported with good result and need to be followed until the next five years.

Copyright
© 2022 The Authors. Published by Atlantis Press International B.V.
Open Access
This is an open access article under the CC BY-NC license.

Download article (PDF)

<Previous Article In Volume
Next Article In Volume>
Volume Title
Proceedings of the 2nd Global Health and Innovation in conjunction with 6th ORL Head and Neck Oncology Conference (ORLHN 2021)
Series
Advances in Health Sciences Research
Publication Date
21 February 2022
ISBN
10.2991/ahsr.k.220206.038
ISSN
2468-5739
DOI
10.2991/ahsr.k.220206.038How to use a DOI?
Copyright
© 2022 The Authors. Published by Atlantis Press International B.V.
Open Access
This is an open access article under the CC BY-NC license.

Cite this article

risenwbib
TY  - CONF
AU  - Riska Handriani
AU  - Fadhlia Fadhlia
AU  - Benny Kurnia
PY  - 2022
DA  - 2022/02/21
TI  - Management of Stage II Sinonasal Carcinoma (T2N0M0) with Transnasal Endoscopic Resection and Radiotherapy
BT  - Proceedings of the 2nd Global Health and Innovation in conjunction with 6th ORL Head and Neck Oncology Conference (ORLHN 2021)
PB  - Atlantis Press
SP  - 200
EP  - 205
SN  - 2468-5739
UR  - https://doi.org/10.2991/ahsr.k.220206.038
DO  - 10.2991/ahsr.k.220206.038
ID  - Handriani2022
ER  -